INVITED REVIEW - Inherited skeletal muscle disorders

References

• ADAMS, M. D., DUBNICK, M, KERLAVAGE, A. R., MORENO, R., KELLEY, J. M., UTTERBACK, T R., NAGLE, J. W, FIELDS, C., and VENTER, J. C., 1992, Sequence identification of 2,375 human brain genes. Nature, 355, 632–634.
   PubMed Web of Science ®Google Scholar
• ADINOLFI, M., ELHASHEMITE, N., SHERLOCK, J., WARD, R. H. T, PETROU, M.AND RODECK, C., 1997, Prenatal detection of Hb mutations using transcervical cells. Prenatal Diagnosis, 17, 539–543.
   Google Scholar
• ANDERSON, S., BANKER, A. T, BARRELL, B. G., DE BRUHN, M. H. L, COUISON, A. R., DROUIN, J., EPERON, I. C., NIERLICH, D. P., ROE, B. A., SANGER, F., SCHREIER, P. H., Smrrx, A. J. H., STADEN, R., and YOUNG, I. G., 1981, Sequence and organization of the human mitochondrial genome. Nature, 290, 457–465.
   Google Scholar
• ANON, 1998, Human trials set for DMD. Quest, 5, 9–10.
   Google Scholar
• ASKANAS, V., 1997, New developments in hereditary inclusion body myopathies. Annals of Neurology, 41, 421–422.
   PubMedGoogle Scholar
• ASLANIDLS, C., JANSEN, G., AMEMIYA, C., SHUTLER, G., lvba—HADEVAN, M, TSILFIDLS, C., CHEN, C., ALLEMAN, J., WORMSKAMP, N. G. M., Voorrs, M., BUXTON, J., JOHNSON, K, SMEETS, H. J. m., LENNON, G. G., CARRANO, A. V., KORNELUK, R. G., WIERINGA, B., and DE JONG, P. J., 1992, Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature, 355, 548–550.
   Google Scholar
• BANKER, B. Q., 1994, The congenital muscular dystrophies. In A. G. Engel and C. Franzini-Armstrong (eds) Myology (New York: McGraw-Hill Inc), pp. 1275–1289.
   Google Scholar
• BANKER, B. Q.AND ENGEL, A. G., 1994, Basic reactions of muscle. In A. G. Engel and C. Franzini-Armstrong (eds) Myology (New York: McGraw-Hill Inc), pp. 832–888.
   Google Scholar
• BASHIR, R., BRITTON, S., STRACHAN, T, KEE:RS, S., VAFTADAKI, E., LAKO, m., RICHARD, I., MARCHAND, S., BOURG, N., ARGOV, Z., SADEH, M., MAHJNEII, I., MARCONI, G., PASSOS-BUENO, M., MOREIRA, E., ZATZ, M., BECKMANN, J., and BUSHBY, K., 1998, A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nature Genetics, 20, 37–42.
   Google Scholar
• BIONE, S., MAESTRINI, E., RIVET A, S., MANCINI, M, REGIS, S., Romoo, G., and TONIOLO, D., 1994, Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nature Genetics, 8, 323–327.
   PubMed Web of Science ®Google Scholar
• BONNEMANN, C. G., Morn, R., NOGUCHI, S., MIZUNO, Y., YOSHIDA, M., GUSSONI, E., MCNALLY, E. M., DUGGAN, D. J., ANGELINI, C., HOFFMAN, E. P., OZAWA, E., and KUNKEL, L M., 1995, b-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy wih loss of the sarcoglycan complex. Nature Genetics, 11, 266–273.
   PubMed Web of Science ®Google Scholar
• BOTSTEIN, D., WHITE, R. L, SKOLNICK, M., and DAVIS, R. W. (1980) Construction of a genetic linkage map in man using restriction fragment length polymorphisms. American Journal of Human Genetics, 32, 314–331.
   PubMed Web of Science ®Google Scholar
• BOUCHER, C. A., KING, S. K, CAREY, N., KRAHE, R., WINCHESTER, C. L, RAH:MANN, S., CREAVIN, T, MEGHJI, P., BAILEY, M E. S., CHARTIER, F. L, BROWN, S. D., SICILIAN°, M. J., and JOHNSON, K. J., 1995, A novel homeodomain-encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable (CTG)n repeat. Human Molecular Genetics, 4, 1919–1925.
   Google Scholar
• BRADLEY, D. M, PARSONS, E. P., and CLARKE, A. J., 1993, Experience with screening newborns for Duchenne muscular dystrophy in Wales. British Medical Journal, 306, 357–360.
   PubMedGoogle Scholar
• BRATS, B., BOUCHARD, J.-P., XrE, Y.-G., ROCHEFORT, D. L, CHRETIEN, N., TOME, F. M. S., LAFRENIERE, R. G., ROMMENS, J. M., UYAMA, E., NOHIRA, 0., BLUMEN, S., KORCYN, A. D., HEUTINK, P., MATHIEU, J., DURANCEAU, A., CODERE, F., FARDEAU, M., and ROULEAU, G. A., 1998, Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nature Genetics, 18, 164–167.
   Google Scholar
• BREWSTER, B., GROENEN, P., and WIERINGA, B., 1998, Myotonic Dystrophy: clinical and molecular aspects. In A. E. H. Emery (ed.) Neuromuscular Disorders: Clinical and Molecular Genetics (Chichester & New York: John Wiley and Sons), pp. 323–364.
   Google Scholar
• BUSBY, M., and SQUIER, M, 1998, Central core disease. In A. E. H. Emery (ed.) Neuromuscular disorders: clinical and molecular genetics (Chichester & New York: John Wiley and Sons).
   Google Scholar
• BUSHBY, K M. D., HILL, A., and STEELE, J. G., 1999, Failure of early diagnosis in symptomatic LTuchenne muscular dystrophy. The Lancet, 353, 557–558.
   Google Scholar
• BUXTON, J., SHELBOURNE, P., DAVIES, J., Jo, C., VAN TONGEREN, T, ASLANIDLS, C., DE JONG, P., JANSEN, G., ANvimr, M., RILEY, B., WILLIANEON, R., and JouNsoN, K, 1992, Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature, 355, 547–548.
   PubMed Web of Science ®Google Scholar
• CHEUNG, V. G., GREGG, J. P., GOGOLINEWENS, K J., BANDONG, J., STANLEY, C. A., BAKER, L, HIGGINS, M. J., NOWAK, N. J., SHOWS, T B., EWENS, W. J., and SPIELMAN, R. S., 1998, Linkage-Disequilibrium Mapping Without Genotyping. Nature Genetics, 18, 225–230.
   PubMed Web of Science ®Google Scholar
• CHLC:, MURRAY, J. C., Bugrow, K. H., WEBER, J. L, T-DWIGSEN, S., SCHERPBIER-HEDDEMA, T, MANION, F., QUILLEN, J., SHEFFIELD, V. C., SUNDEN, S., DUYK, G. M., GENETHON: WEISSINBACH, J., GYAPAY, G., DI13, C., MORRLSSETTE, J., LATHROP, G. M., VIGNAL, A., UTAH: U. o., WHITE, R., MATSUNAMI, N., GERKEN, S., MELTS, R., ALBERTSEN, H., PLAETKE, R., ODELBERG, S., UNIVERSITY: Y., WARD, D., (CEPH): C. D. E. D. P. H., DAUSSET, J., COHEN, D., CANN, H., 1994, A comprehensive human linkage map with centimorgan density. Science, 265, 2049–2054.
   Google Scholar
• CLARK, K M., BINDOFF, L A., LIGHTOWLERS, R. N., ANDREW, R. M., GRIFFITHS, P. G., JOHNSON, M A., BRIERLEY, E. J., and TURNBULL, D. m., 1997, Reversal of a Mitochondrial DNA Defect in Human Skeletal Muscle. Nature Genetics, 16, 222–224.
   PubMed Web of Science ®Google Scholar
• COHEN, D., CHUMAKOV, I., and WEISSENBACH, J., 1993, A first-generation physical map of the human genome. Nature, 366, 698–701.
   PubMed Web of Science ®Google Scholar
• COLLINS, F. S., 1995, Positional cloning moves from perditional to traditional. Nature Genetics, 9, 347–350.
   PubMed Web of Science ®Google Scholar
• DI DONATO, S., 1994, Disorders of lipid metabolism affecting skeletal muscle: carnitine deficiency syn-dromes, defects in the catabolic pathway adn Chanarin disease. In A. G. Engel and C. Franzini-Armstrong (eds) Myology (New York: McGraw-Hill Inc.), pp. 1587–1609.
   Google Scholar
• DUSOWNZ, V., 1992, Myoblast transfer in muscular dystrophy: panacea or pie in the sky? Neuromuscular disorders, 2, 305–310.
   PubMedGoogle Scholar
• DUNCKLEY, M. G., MANOHARAN, M., VILLIET, P., EPERON, I. C., and DICKSON, G., 1995, Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonudeotides. Human Molecular Genetics, 5, 1083–1090.
   Google Scholar
• EDITOR, 1996, To affinityand beyond! Nature Genetics, 14, 367–370.
   PubMedGoogle Scholar
• EDWARDS, J. H., 1986, The population genetics of LTuchenne: natural and artificial selection in LTuchenne muscular dystrophy. Journal of Medical Genetics, 23, 521–530.
   PubMedGoogle Scholar
• EMERY, A. E. H., 1998, Molecular Genetics of Neuromuscular Disorders: applications in clinical medicine. In A. E. H. Emery (ed.) Neuromuscular Disorders: clinical and molecular genetics (Chichester & New York: John Wiley and Sons), pp. 1–20.
   Google Scholar
• FARDEAU, M., and Tox/th, F. M. S., 1994, Congenital myopathies. In A. G. Engel and C. Franzini-Armstrong (eds) Myology (New York: McGraw-Hill Inc,), pp. 1487–1532.
   Google Scholar
• FIELDS, S., and SONG, O-K, 1989, A novel genetic system to detect protein-protein interactions. Nature, 340, 245–246.
   PubMed Web of Science ®Google Scholar
• FUJI', J., OTSU, K, ZORZATO, F., DE LEON, S., AL, E., and MCLENNAN, D. H., 1991, Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science, 253, 448–451.
   Google Scholar
• GARLEPP, M. J., LAING, B., ZILKO, P. J., OLLIER, W. AND MASTAGLIA, F. L, 1994, HLA associations in inclusion body myositis. Clinical and Experimental Immunology, 98, 10 45.
   Google Scholar
• GILLARD, E. F., OTSU, K, Fuji', J., KHANNA, V. K, DE LEON, S., DEREDKVIEZ I, J., BRITT, B. A., DUFF, C. L, WORTON, R. G., and MACLENNAN, D. H., 1991, A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia. Genomics, 11, 751–755.
   Google Scholar
• GILMAN, S., GOLDSTEIN, G. W., and WAXMAN, S. G., 1998, Neurobase [monograph on CD-ROM] (La Jolla, CA: Arbor Publishing).
   Google Scholar
• GOLDFARB, L G., PARK, K -Y., CERVENAKOVA, L, GOROKHOVA, S., T FF, H.-s., VASCONCELOS, O., NAGLE, J. W SEMINO-MORA, C., SIVAKUMAR, K, and DALAKAS, M. C., 1998, Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nature Genetics, 19, 402–41)3.
   Google Scholar
• GOWERS, W. R., 1902, A lecture on myopathy and a distal form. British Medical Journal, 2, 89–92.
   PubMedGoogle Scholar
• GYAPAY, G., 1VORLSEI1E, J., VIGNAL, A., Dm, C., FIZ AMES, C., MILLASSEAU, P., MARC, S., BERNARDI, G., LATHROP, M., and WEISSENBACH, J., 1994, The 1993–94 Genethon human genetic linkage map. Nature Genetics, 7, 246–339.
   Google Scholar
• GYAPAY, G., SCH1VIIIT, K, FIZAMES, C., JONES, H., VEGA-CZARNY, N., SPILLET, D., MUSELET, D., PEuD'HoivAlE, J-F., Dm, C., AUFFRAY, C., MORISETTE, J., WEISSENBACH, J., and GOODFELLOW, P. N., 1996, A radiation hybrid map of the human genome. Human Molecular Genetics, 5, 339–346.
   Google Scholar
• HALDANE, J. B. S., 1935, The rate of spontaneous mutation of a human gene. Journal of Genetics, 31,317–326.
   Google Scholar
• HARAVUORI, H., MAKELA-BENGS, P., UDD, B., PARTANEN, J., PULKKINEN, L, SOMER, H., and PELTONEN, L, 1998, Assignment of the tibial muscular dystrophy locus to chromosome 2q31. American Journal of Human Genetics, 62, 620–626.
   Google Scholar
• HARLEY, H. G., BROOKE, J. D., RUNDLE, S. A., CROW, S., REARDON, W., BUCKLER, A. J., HARPER, P. S., HOUSMAN, D. E., and SHAW, D. J., 1992, Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature, 355, 545–546.
   PubMed Web of Science ®Google Scholar
• HAYASHI, Y. K, CHOU, F. L, ENGVALL, E., OGAWA, M., MATSUDA, C., HIRABAYASIE, S., YOKOCHI, K., ZIOBER, B. L, KRAMER, R. H., KAUFMAN, S. J., OZAWA, E., GOTO, Y., NONAKA, I., TSUKAHARA, T, WANG, J. Z., HOFFMAN, E. P., and ARAHATA, K., 1998, Mutations in the Integrin Alpha-7 Gene Cause Congenital Myopathy. Nature Genetics, 19, 94–97.
   PubMed Web of Science ®Google Scholar
• HELBLING-IECLERC, A., ZHANG, X, TOPALOGLU, H., CRUAUD, C., TESSON, F., WEISSENBACH, J., TOME, F. M S., SCWARTZ, K, FARDEAU, M., TRYGGVASON, K, and GUICHENEY, P., 1995, Mutations in the laminin a2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nature Genetics, 11, 216–218.
   Google Scholar
• HEWITT, J. E., LyLE, R., CLARK, L N., VALLELEY, E. M., WRIGHT, T J., WIJMENGA, C., VAN DEUTEKOM, J. C. T, FRANCIS, F., SHARPE, P. T, HOFKER, m., FRANTS, R. R., and WILLIAMSON, R., 1994, Analysis of the tandem repeat locus D4Z4 associated with facioscapulo-humeral muscular dystrophy. Human Molecular Genetics, 3,1287–1295.
   Google Scholar
• HOFFMAN, E. P., BROWN, R. H., and KUNKEL, L M., 1987, Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell, 51, 919–928.
   PubMed Web of Science ®Google Scholar
• HUDSON, T J., STEIN, L D., GERETY, S. S., MA, J. L, CASTLE, A. B., SILVA, J., SLONIM, D. K, BAPTLSTA, R., KRUGLYAK, L, XU, S. H., Hu, X T, COLBERT, A. M E., ROSENBERG, C., REEVEDALY, m. P., ROZEN, S., HUI, L, Wu, X. Y., VESTERGAARD, C., WILSON, K M., BAE, J. S., MAITRA, S., GANIATSAS, S., EVANS, C. A., DEANGELLS, M. M., INGALLS, K. A., and AL, E., 1995, An STS-based map of the human genome. Science, 270, 1945–1954.
   Google Scholar
• IKEUCHI, T, ASAKA, T, SAITO, M., TANAKA, H., HiGucm, S., TANAKA, K, SAIDA, K., UYAMA, E., MIZUSAWA, H., FUKUHARA, N., NONAKA, I., TAKA1VDRI, M., and Tsuji, S., 1997, Gene locus for autosomal recessive distal myopathy with rimmed vacuoles maps to chromosome 9. Annals of Neurology, 41, 432–437.
   Google Scholar
• JOBSIS G. J., KEIZERS, H., VREIJLING, J. P., DE V. M, SPEER, M. C., WOLTERMAN, R. A., BAAS, F. AND BOLHUIS, P. A., 1996, Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures. Nature Genetics, 14, 113–115.
   Google Scholar
• KARPAT,I, G., 1984, Mitigation of deleterious effects of certain abnormal genes in immature skeletal muscle cells. Trends in Neurosciences, 7, 360–361.
   Google Scholar
• KLESERT, T R., OrrEN, A. D., BIRD, T D., and TAPSCUTT, S. J., 1997, Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP. Nature Genetics, 16, 402–406.
   PubMed Web of Science ®Google Scholar
• KOENIG, M., HOFFMAN, E. P., BERTELSON, C. J., MONACO, A. P., FEENER, C., and KUNKEL, L M., 1987, Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell, 50, 509–517.
   PubMed Web of Science ®Google Scholar
• KUBISCH, C., llivi[DT-RosE, T, FONTAINE, B., BRETAG, A. H., and JENTSCH, T J., 1998, C1C-1 chloride channel mutations in myotonia congenita: variable penetrance of mutations shifting the voltage dependence. Human Molecular Genetics, 7, 1753–1760.
   Google Scholar
• LAING, N. G., 1995, Inherited disorders of contractile proteins in skeletal and cardiac muscle. Current Opinion in Neurology, 8, 391–396.
   PubMedGoogle Scholar
• LAING, N. G., LAING, B. A., MEREDITH, C., WILTON, S. D., ROBBINS, P., HONEYMAN, K, DOROSZ, S., KOZMAN, H., MASTAGLIA, F. L, and KAKULAS, B. A., 1995a, Autosomal dominant distal myo-pathy: linkage to chromosome 14. American Journal of Human Genetics, 56, 422–427.
   PubMed Web of Science ®Google Scholar
• LAING, N. G., WILTON, S. D., AKKARI, P. A., DOROSZ, S., BOUNDY, K, KNEEBONE, C., BLUMBERGS, P., WHITE, S., WATiciNs, H., LDVE, D. R., and HAAN, E. A., 1995b, A mutation in the a-tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy. Nature Genetics, 9, 75–79.
   PubMedGoogle Scholar
• LAPORTE, J., Hu, L J., KRETZ, C., MANDEL, J.-L, KIOSCHLS, P., COY, J. F., KLAUCK, S. M., POUSTKA, A., and DAHL, N., 1996, A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nature Genetics, 13, 175–182.
   Google Scholar
• LEHMANN-HORN, F., and RUDEL, R., 1995, Hereditary nondystrophic myotonias and periodic paralyses. Current Opinion in Neurology, 8, 402–410.
   PubMedGoogle Scholar
• LIU, J., AOKI, M., ILLA, I., WU, C., FARDEAU, M, ANGELINI, C., SERRANO, C., URTIZBEREA, J., HENTATI, F., BEINHA1VHDA, m., BOHLEGA, S., CULPER, E., AMATO, A., BOSSE, K, OELTJEN, T, BEJAOUL K., MCKENNA-YASEK, D., HOSLER, B., SCHURR, E., ARAHATA, K., DEJONG, P., and BROWN, R., 1998, Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nature Genetics, 20, 31–36.
   Google Scholar
• LO, Y. M. D., CORBETTA, N., CHAMBERLAIN, P. F., RAI, V., SARGENT, I. L, REDMAN, C. W. G., and WAINSCOAT, J. S., 1997, Presence of Foetal DNA in Maternal Plasma and Serum. The Lancet, 350, 485–487.
   Google Scholar
• MAHADEVAN, m., TSILFIDLS, C., SABOURIN, L, SHUTLER, G., AMEMIYA, C., JANSEN, G., NEVILLE, C., NARANG, M., BARCELO, J., O'HOY, K, IRBLOND, S., EARLE-MACDONALD, J., DE JONG, P. J., WIERINGA, B., and KORNELUK, R. G., 1992, Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science, 255, 1253–1255.
   Google Scholar
• MCNALLY, E. M., Ly,C. T, and KUNKEL, L M., 1998a, Human e-sarcoglycan is highly related to a-sarcoglycan (Adhalin), the limb girdle muscular dystrophy 2D gene. FEBS Letters, 422, 27–32.
   Google Scholar
• MCNALLY, E. M., MOREIRA, E. D., DUGGAN, D. J., LISANTI, M. P., LIDOV, H. G. W, VAINZOF, M, BONNEMANN, C. G., PASSOSBUENO, M. R., HOFFMAN, E. P., ZATZ, m., and KUNKEL, L M, 1998b, Caveolin-3 in Muscular Dystrophy. Human Molecular Genetics, 7, 871–877.
   Google Scholar
• MINETTI, C., SOTGIA, F., BRUNO, C., SCARTEZZINI, P., BRODA, P., BADO, M., MASETTI, E., MAZZOCCO, M, EGEO, A., DONATI, M A., VOLONTE, D., GALBIATI, F., CORDONE, G., BRICARELLI, F. D., LTSANTI, M P., and ZARA, F., 1998, Mutations in the Caveolin-3 Gene Cause Autosomal Dominant Limb-Girdle Muscular Dystrophy. Nature Genetics, 18, 365–368.
   PubMed Web of Science ®Google Scholar
• MITRANI-ROSENBAUM, S., ARGOV, Z., BLUMENFELD, A., SEIDMAN, C. E., and SEIDMAN, J. G., 1996, Hereditary inclusion body myopathy maps to chromosome 9p1-ql. Human Molecular Genetics, 5, 159–163.
   Google Scholar
• MONACO, A. P., BERTELSON, C. J., LIFCHTI-GALLATI, S., MOSER, H., and KUNKEL, L M., 1988, An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics, 2, 90–95.
   Google Scholar
• NEUMEYER, A. M., CROS, D., MCKENNA-YASEK, R. N., ZAWADZ KA, A., HOFFMAN, E. P., PEGORARO, E., HUNTER, R. G., MUNSAT, T L, and BROWN JR, R. H., 1998, Pilot study of myoblast transfer in the treatment of Becker muscular dystrophy. Neurology, 51, 589–592.
   Google Scholar
• NIGRO, V., DE SA MOREIRA, E., PILUSO, G., VAINZOF, M., BELLSTO, A., POLITANO, L, PUCA, A. A., PASSOS-BUENO, M R., and ZATZ M., 1996, Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the d-sarcoglycan gene. Nature Genetics, 14, 195–198.
   Google Scholar
• NOGUCHI, S., MCNALLY, E. M., OTHMANE, K. B., HAGIWARA, Y., MIZUNO, Y., YOSHIDA, M., YAMAMOTO, H., BONNEMANN, C. G., GUSSONI, E., DENTON, P. H., KYRIAKIDES, T, MIDDLETON, L, HENTATI, F., HAIVIIDA, M. B., NONAKA, I., VANCE, J. m., KUNKEL, L M., and OZAWA. E., 1995, Mutations in the dystrophin-associated protein g-sarcoglycan in chromosome 13 muscular dystrophy. Science, 270, 819–822.
   Google Scholar
• NORTH, K N., and BEGGS, A. H., 1996, Deficiency of a skeletal muscle isoform of a-actinin (a-actinin 3) in merosin positive congenital muscular dystrophy. Neuromuscular Disorders, 6, 229–235.
   PubMed Web of Science ®Google Scholar
• NORTH, K N., YANG, N., WATTANASIRICHAIGOON, D., MILLS, M., KIM, S., TONG, H. Q., and BEGGS, A. (1998) Functional redundancy of the human muscle actin-binding protein, a-actinin-3. Muscle and Nerve, Supplement 7, S200.
   Google Scholar
• OZAWA, E., NOGUCHI, S., MIZUNO, Y., HAGIWARA, Y., and YOSHIDA, M., 1998, Invited review - from dystrophinopathy to sarcoglycanopathy — evolution of a concept of muscular dystrophy. Muscle & Nerve, 21, 421–438.
   PubMed Web of Science ®Google Scholar
• PALLAVICINI, A., ZIVIBELLO, R., 'Esc), N., MURARO, T, RAMPOLDI, L, BORTOLUZZI, S., VALLE, G., LANFRANCHI, G., and DANIELI, G. A., 1997, The preliminary transcript map of a human skeletal muscle. Human Molecular Genetics, 6, 1445–1450.
   Google Scholar
• PAN, T C., ZHANG, R. Z., PERICAK-VANCE, M A., TANDAN, R., FRIES, T, STAJICH, J. M., VILES, K, VANCE, J. M., CHU, M. L, and SPEER, m. C., 1998, Missense mutation in a von Willebrand factor type A domain of the a-3(VI) collagen gene (COL6A3) in a family with Bethlem myopathy. Human Molecular Genetics, 7, 807–812.
   Google Scholar
• PELIN, K, HILPEL, P., Doi, K, SEWRY, C., AKKARI, P. A., WILTON, S. D., WATTANASIRICHAIGOON, D., CENTNER, T, HANEFELD, F., ODENT, S., FARDEAU, M., URTIZBEREA, J. A., MUNTONI, F., DUBOWITZ V., BEGGS, A. H., LUNG, N. G., LABEIT, S., DE LA CHAPELLE, A., and WALLGREN-PETTERSSON, C., 1999, Mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Proceedings of the National Academy of Sciences of the USA, 96, 2305–2310.
   Google Scholar
• PELIN, K, RIDANPAA, M., Do', K, WILTON, S., KRLSHNARAJAH, J., LAING, N., KOLMERER, B., LABEIT, S., DE LA CHAPELLE, A., and WALLGREN-PETTERSSON, C., 1997, Refined localization of the genes for nebulin and titin on chromosome 2q allows the assignment of nebulin as a candidate gene for autosomal recessive nemaline myopathy. European Journal of Human Genetics, 5, 229–234.
   Google Scholar
• QUANE, K A., HEALY, J. M. S., KEATING, K E., MANNING, B. M., COUCH, F. J., PALMUCCI, L M, DORIGUZZI, C., FAGERLAND, T H., BERG, K, ORDING, H., BENDDCEN, D., MORTIER, W., LINZ, U., MULLER, C. R., and MCCARTHY, T V., 1993, Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nature Genetics, 5, 51–55.
   Google Scholar
• RAFAEL, J. A., TINSLEY, J. M., POTTER, A. C., DECONINCK, A. E., and DAVIS, K E., 1998, Skeletal Muscle-Specific Expression of a Utrophin Transgene Rescues Utrophin-Dystrophin Deficient Mice. Nature Genetics, 19, 79–82.
   PubMed Web of Science ®Google Scholar
• RANUM L P. W., RASMUSSEN, P. F., BENZOW, K A., Koos, M. D., and DAY, J. W., 1998, Genetic Mapping of a Second Myotonic Dystrophy Locus. Nature Genetics, 19, 196–198.
   PubMed Web of Science ®Google Scholar
• RICHARD, I., BROUX, O., ALLAMAND, V., FOUGEROUSSE, F., CHIANNILKULCHI, N., BOURG, N., BRENGUIER, L, DEVAUD, C., PASTURAUD, P., ROUDAUT, C., HILLAIRE, D., PASSOS-BUENO, m.-R., ZATZ, M., TISCHFIELD, J. A., FARDEAU, M, JACKSON, C. E., COHEN, D., and BECKMANN, J. S., 1995, Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell, 81, 27–40.
   Google Scholar
• RICKER, K., GRIMM, T, KOCH, M C., SCHNEIDER, C., KRESS, W., REIMERS, C. D., SCHULTE-MATTLER, W., MUELLER-MYHSOK, B., TOYKA, K V., and MUM" ER, C. R., 1999, Linkage of proximal myotonic myopathy to chromosome 3q. Neurology, 52, 170–171.
   Google Scholar
• RICKER, K, KOCH, m. c., ha-IMANN-HORN, F., PONGRATZ, D., SPEICH, N., REINERS, K., SCHNEIDER, C. AND MOXLEY III, R. T, 1995, Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy. Archives of Neurology, 52, 25–31.
   Google Scholar
• ROBERDS, S. L, LETURQ, F., ALLAMAND, V., PICCOLO, F., JEANPIERRE, M., ANDERSON, R. D., LEM, L E., T FE, J. C., TOME, F. M. S., ROMERO, N. B., FARDEAU, M., BECKMAN, J. S., KAPLAN, J-C., and CAMPBELL, K P., 1994, Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell, 78, 625–633.
   Google Scholar
• SHY, G., ENGEL, W., SOMERS, J., and WANKO, T, 1963, Nemaline myopathy: a new congenital myopathy. Brain, 86, 793–810.
   PubMed Web of Science ®Google Scholar
• SIMPSON, J. L, and ELIA SS. (1993) Isolating foetal cells from maternal blood. Advances in prenatal diagnosis through molecular technology. Journal of the American Medical Association, 270, 2357–2361.
   PubMed Web of Science ®Google Scholar
• SUOMALAINEN, A., KAUKONEN, J., AMATI, P., TIMONEN, R., HALTIA, M., WEISSENBACH, J., ZEVIANI, M., SOMER, H., and PELTONEN, L, 1995, An autosomal locus predisposing to deletions of mitochon-drial DNA. Nature Genetics, 5, 146–151.
   Google Scholar
• SUTHERS, G., LAING, N. G., WILTON, S. D., DOROSZ, S., and WADDY, H., 1994, "Sporadic" motoneuron disease due to familial SOD1 mutation with low penetrance. The Lancet, 344, 1773.
   PubMedGoogle Scholar
• TAN, P., ALLEN, J. G., WILTON, S. D., AKKARI, P. A., HUXTABLE, C. R., and LAING, N. G., 1997, A splice-site mutation causing ovine McArdle's disease. Neuromuscular Disorders, 7, 336–342.
   PubMedGoogle Scholar
• THORNTON, C. A., GRIGGS, R. C., and MOXLEY III, R. T, 1994, Myotonic dystrophy with no trinucleotide repeat expansion. Annals of Neurology, 35, 269–272.
   PubMedGoogle Scholar
• THORNTON, C. A., WYMER, J. P., SINEVIONS, Z., MCCLAIN, C., and MOXLEY, R. T, 1997, Expansion of the Myotonic Dystrophy CTG Repeat Reduces Expression of the Flanking DMAHP Gene. Nature Genetics, 16, 407–409.
   PubMed Web of Science ®Google Scholar
• TINSLEY, J. M., POTTER, A. C., PHELPS, S. R., FISHER, R., TsicssrT, J. I., and DAVIES, K. E., 1996, Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature, 384, 349–353.
   PubMed Web of Science ®Google Scholar
• UDD, B., HARAVUORI, H., KALINIO, H., PARTANEN, J., PULKKINEN, L, PAETAU, A., PELTONEN, L, and SOMER, H., 1998, Tibial Muscular Dystrophy — From Clinical Description to Linkage On Chromosome 2q31. Neuromuscular Disorders, 8, 327–332.
   PubMed Web of Science ®Google Scholar
• UDD, B., PARTANEN, J., HALONEN, P., FALCK, B., HAKAMIES, L, HEIKKILA, H., INGo, S., KALEVID, H., KAARIANEN, H., LAULUMAA, V., PALJARVI, L, RAPOLA, J., REUNANEN, M., SONNINEN, V., and SOMER, H., 1993, Tibial muscular dystrophy: late-onset distal myopathy in 66 Finnish patients. Archives of Neurology, 50, 604–608.
   PubMedGoogle Scholar
• VAINZOF, M., COSTA, C. S., MARIE, S. K, MOREIRA, E. S., REED, U., PASSOSBUENO, MR., BEGGS, A. H. AND ZATZ, M., 1997, Deficiency of Alpha-Actinin-3 (ACTN3) Occurs in Different Forms of Muscular Dystrophy. Neuropediatric4 28, 223–228.
   Google Scholar
• VAINEZOF, M, PASSOS-BUENO, M. R., CANOVAS, M., MOREIRA, E. S., PAVANELLO, R. C. M., MARIE, S. K., ANDERSON, L V. B., BONNEMANN, C. G., MCNALLY, E. M., NIGRO, V., KUNKEL, L M., and ZATZ, M,. 1996, The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies. Human Molecular Genetics, 5, 1963–1969.
   Google Scholar
• VICART, P., CARON, A., GUICHENEY, P., Li, Z., PREVOST, M., FAURE, A., CHATEAU, D., CHAPON, F., TOME, F., DUPREE, J., PAULIN, D., and FARDEAU, M., 1998, A missense mutation in the aB-crystallin chaperone gene causes a desmin-related myopathy. Nature Genetics, 20, 92–95.
   PubMed Web of Science ®Google Scholar
• WALD, N., CUCKLE, H., DENSEM, J., NANCHAHAL, K, ROYSTON, P., CHARD, T, HADDOW, J., and AL, E., 1988, Maternal serum screening for Down's syndrome in early pregnancy. British Medical Journal, 297, 883–887.
   PubMed Web of Science ®Google Scholar
• WALLGREN-PETTERSSON, C., AVELA, K, MARCHAND, S., KOLEIMAINEN, J., TAHVANAINEN, E., JUUL-HANSEN, F. J., MUNTONI, F., DUBOWITZ, V., DE VISSER, M., VAN LANGEN, I. M., LAING, N. G., FAURE, S. AND DE LA CHAPEL" E, A., 1995, A gene for autosomal recessive nemaline myopathy assigned to chromosome 2q by linkage analysis. Neuromuscular Disorders, 5, 441–443.
   Google Scholar
• WIJMENGA, C., HEWITT, J. E., SANDKUIJL, L A., CLARK, L N., WRIGHT, T J., DAUWERSE, H. G., GRUTER, A.-M., HOFKER, M. H., Mom, P., WILLIA1VEON, R., VAN OMMEN, G-J. B., PADBERG, G. W AND FRANTS, R. R., 1992, Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nature Genetics, 2, 26–30.
   Google Scholar
• WILLIAMSON, R. A., HENRY, m. D., DANIELS, K J., HRSTKA, R. F., T FF, J. C., SUNADA, Y., IBRAGIIIMOV-BESKROVNAYA, O., and CAMPBELT K P., 1997, Dystroglycan is essential for early embryonic development — disruption of Reicherts-membrane in Dagl-null mice. Human Molecular Genetics, 6, 831–841.
   Google Scholar
• WILTON, S. D., DYE, D., BLECHYNDEN, L, and LAING, N., 1997, Revertant Fibres: a possible genetic therapy for LTuchenne muscular dystrophy? Neuromuscular Disorders, 7, 329–335.
   PubMed Web of Science ®Google Scholar
• ZHANG, Y., Cr, H. S., KT-TA—NNA, V. K., DE LEON, S., PHILLIPS, M. S., SCHAPPERT, K., BRITT, B. A., BROWNEL, K. W., and MACLENNAN, D. H., 1993, A mutation in the human ryanodine receptor gene associated with central core disease. Nature Genetics, 5, 46–50.
   Google Scholar